For the once-weekly subcutaneous formulation, the SUSTAIN program (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) included 13 separate randomized clinical phase 3a and 3b trials ( Table 1 Overview of Phase 3 studies of oral semaglutide (PIONEER) and subcutaneous semaglutide (SUSTAIN) ( *Phase 3b trials all others are phase 3a trials CKD, chronic kidney disease
Factors that influence early weight loss include starting body weight, baseline diet quality, physical activity level, hydration status, and individual metabolic rate
For more detail on storage timelines, you can also refer to our blog on how long a vial of semaglutide lasts
When to Pay Attention to Changes in Bathroom Habits Mild constipation happens often, but long-lasting stomach problems need attention
Findings from the SELECT trial suggested that Wegovy has the potential to transform care for people with overweight and obesity who also have heart disease